| This week's sponsor is Premier Research. | | | Rare Oncology Drug Advances. What's In It For You?
Take a look at how new drug development processes and regulatory pathways are helping speed development of novel therapies, including adaptive design strategies, endpoint selection, and effectively using biomarkers. Download our latest white paper now.
Premier Research. It's what we do. Best. |
Featured Story | | | Tuesday, June 13, 2017 Acceleron Pharma has jettisoned dalantercept after the inhibitor of ALK1 signaling failed to move the needle in a phase 2 kidney cancer trial. The setback intensifies the focus on Acceleron’s lead, Celgene-partnered rare blood disease drug luspatercept. |
|
|
| This week's sponsor is Medpace. | | | |
Top Stories Tuesday, June 13, 2017 The three drug regulators from Europe, the U.S. and Japan have come together in a data share program aimed at boosting antibiotic development. Tuesday, June 13, 2017 OSE Immunotherapeutics has teamed up with Memorial Sloan Kettering Cancer Center to work on its anti-CD127 antibody OSE-703. The research program will assess the potential for the candidate to treat non-small cell lung cancer (NSCLC) and other solid tumors. Monday, June 12, 2017 “Patient centricity must be grounded in an engagement approach for the patients … ” Jonathan Zung, PhD, Covance. How do clinical research organizations (CROs) respond and support this increasing focus on patient-centric practices? Tuesday, June 13, 2017 Under-pressure microRNA biotech Regulus has promoted Mark Deeg into a new role as chief medical officer. Tuesday, June 13, 2017 With three positive phase 3 trials in hand, Eli Lilly heads for the FDA with migraine drug galcanezumab in pursuit of Amgen/Novartis. Monday, June 12, 2017 Researchers from the Washington University School of Medicine found that injecting trehalose, a naturally occurring sugar, reduced arterial plaque in mice. They aim to create an oral version of the treatment for atherosclerosis. Monday, June 12, 2017 Qualcomm and Johnson & Johnson’s LifeScan unit have teamed up to enable wireless data collection for one of the latter’s blood glucose meters. Monday, June 12, 2017 There’s officially another heart-helping SGLT2 on the block. But this one brings some varied benefits—and amputation risks—along with it. Tuesday, June 13, 2017 A second U.S. appeals court has blocked President Donald Trump’s revised travel ban, and healthcare organizations are asking the Supreme Court not to issue a stay of the injunctions against it, saying it could have a detrimental impact on an industry that depends on foreign doctors and medical students to staff hospitals, clinics and research labs. | This week's sponsor is Cmed. | | | |
| | | Pfizer and Eli Lilly said the FDA has granted a fast-track tag for their osteoarthritis and back pain med tanezumab. Release Daniel Levitt, CytRx's chief operating and medical officer, is stepping down July 7 with his position also set to be cut, while Scott Wieland, its SVP of drug development, will be leaving at the end of this month. Statement Pulmatrix can now access a portfolio of kinase inhibitors after penning a worldwide license pact with Janssen's RespiVert. Release | |
|
Resources Sponsored by Envigo Performing a sophisticated surgery to create a myocardial infarction model. Join us on June 7th at 11:00 AM EDT. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. Sponsored By: HealthCore Gain critical insights into how to design and implement pragmatic trials and generate relevant, high-level real-world evidence. Learn when to conduct PTs, design considerations, ethical regulatory issues — and more. Sponsored By: Veeva Join this global webinar to learn a new approach for demonstrating medical affairs' impact with better metrics - beyond reach and frequency, enabling launch success and better engagement with strategic KOL insights, and increasing your organization's share of voice in the healthcare landscape. Sponsored By: DocuSign DocuSign’s eSignature solutions modernize healthcare and life science organizations by eliminating paper and antiquated signature processes while meeting compliance requirements and reducing costs and errors. Sponsored By: DocuSign The patients who rely on your scientific leadership are expecting more. Sponsored By: DocuSign The U.S. Department of Justice has collected upwards of $17 billion in settlements from the healthcare industry since 2009, including more than $2 billion from a single life sciences company. 2017 BIO International Convention: The Largest Global Biotech Partnering Event of the Year June 19-22 | San Diego, CA Join 1,000 Diagnostics Professionals at Next Generation Dx Summit August 15-18, 2017 | Washington, DC FierceBiotech Executive Breakfast- Tackling the Drug Price Problem: A Town Hall Debate June 21, 2017 | San Diego, CA Drug Development Boot Camp® 2017 November 15-16, 2017 | Boston, MA FierceBiotech 2nd Drug Development Forum September 25-27, 2017 | Boston, MA |
